Evidence map›Paper›PMID 38218814›Full record

ArticleCardiovascular diabetology2024

Sex differences in the association between insulin resistance and non-fatal myocardial infarction across glycaemic states.

Alessia Riccio, Elena Fortin, Linda Mellbin, Anna Norhammar, Per Näsman, Lars Rydén, Giorgio Sesti, Giulia Ferrannini

Open access · goldAbstract read
In one paragraph

Article in Cardiovascular diabetology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Alessia RiccioCardiology Unit, Department of Medicine Solna, Karolinska Institute Stockholm, Stockholm, Sweden. alessia.riccio@uniroma1.it.
Elena FortinCardiology Unit, Department of Medicine Solna, Karolinska Institute Stockholm, Stockholm, Sweden.
Linda MellbinCardiology Unit, Department of Medicine Solna, Karolinska Institute Stockholm, Stockholm, Sweden.
Anna NorhammarCardiology Unit, Department of Medicine Solna, Karolinska Institute Stockholm, Stockholm, Sweden.
Per NäsmanCardiology Unit, Department of Medicine Solna, Karolinska Institute Stockholm, Stockholm, Sweden.
Lars RydénCardiology Unit, Department of Medicine Solna, Karolinska Institute Stockholm, Stockholm, Sweden.
Giorgio SestiDepartment of Clinical and Molecular Medicine, Sapienza University of Rome, Rome, Italy.
Giulia FerranniniCardiology Unit, Department of Medicine Solna, Karolinska Institute Stockholm, Stockholm, Sweden.
Karolinska Institutet · SEKarolinska University Hospital · SEKTH Royal Institute of Technology · SESaint Göran Hospital · SESapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFemales are generally less prone to cardiovascular (CV) events than males, but this protection is trumped by diabetes. The mechanism behind the increased relative risk in females with diabetes is not fully understood. Insulin resistance (IR) is suggested to be a more important contributor to CV morbidity in females than in males. We aim to investigate differences in the association between IR indexes (Homeostatic Model Assessment of IR - HOMA-IR, visceral adiposity index - VAI, and triglycerides/high-density lipoprotein-cholesterol - TG/HDL-C index), and a first non-fatal myocardial infarction (MI) across different glycaemic states.

methodsIR indexes were calculated in a population with (n = 696) and without (n = 707) a first non-fatal MI, free from known diabetes. MI cases were investigated at least six weeks after the event. All participants were categorized by an oral glucose tolerance test as having normal glucose tolerance, impaired fasting glucose, impaired glucose tolerance, or newly diagnosed diabetes. Comparison of proportion of glycaemic states by sex was tested by chi-square test. The associations between sex, a first non-fatal MI, IR indexes, and traditional CV risk factors were analysed by multivariate logistic regression models. Continuous variables were logarithmically transformed.

resultsOf the total population 19% were females and 81% males, out of whom 47% and 50% had a first non-fatal MI, respectively. Compared with males, females were older, less often smokers, with lower body mass index and higher total cholesterol and high-density lipoprotein cholesterol levels. The proportion of glycaemic states did not differ between the sexes (p = 0.06). Females were less insulin resistant than males, especially among cases and with normal glucose tolerance. In logistic regression models adjusted for major CV risk factors including sex, the associations between VAI and TG/HDL-C index and a first non-fatal MI remained significant only in females (odds ratios and 95% confidence intervals: 1.7, 1.0-2.9, and 1.9, 1.1-3.4 respectively).

conclusionsThese results support the assumption that IR indexes based on anthropometrics and lipid panel, i.e., VAI and TG/HDL-C, could be a better measure of IR and CV-predictor for non-fatal MI in females, even without glycaemic perturbations.

Indexed as

Insulin ResistanceMyocardial InfarctionPrediabetic StateBiomarkersBlood GlucoseBody Mass IndexCholesterol, HDLFemaleGlucoseHumansLipoproteins, HDLMaleSex CharacteristicsTriglyceridesBiomarkersBlood GlucoseCholesterol, HDLGlucoseLipoproteins, HDLTriglyceridesCardiovascular diseaseFemalesHOMA-IRPAROKRANKPrediabetesTriglycerides/high-density lipoprotein indexVisceral adiposity index

Identifiers

PMID38218814
PMCPMC10787422
OpenAlexW4390838815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.